{
  "openalex_id": "W4281930285",
  "doi": "https://doi.org/10.1038/d43747-022-00173-8",
  "title": "From drug target inhibition to degradation: a TACtical strategy",
  "abstract": "",
  "authors": [
    {
      "display_name": "Mavra Nasir",
      "id": "A5083906212",
      "orcid": "https://orcid.org/0000-0002-0969-5967",
      "institutions": [
        {
          "id": "I4210115135",
          "display_name": "Healthcentric Advisors",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": true,
      "raw_author_name": "Mavra Nasir"
    },
    {
      "display_name": "Peter Michael Bak",
      "id": "A5013243312",
      "orcid": "https://orcid.org/0000-0002-2639-3012",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Peter Bak"
    },
    {
      "display_name": "Stephan D. Gauldie",
      "id": "A5058498829",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Stephan Gauldie"
    },
    {
      "display_name": "Christopher Leo",
      "id": "A5110322711",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210115135",
          "display_name": "Healthcentric Advisors",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Christopher Leo"
    }
  ],
  "publication_year": 2022,
  "publication_date": "2022-05-19",
  "type": "article",
  "cited_by_count": 3,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S4210231621",
    "display_name": "Biopharma Dealmakers",
    "issn_l": "2730-6275",
    "issn": [
      "2730-6275",
      "2730-6283"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310319965"
  },
  "volume": null,
  "issue": null,
  "first_page": null,
  "last_page": null,
  "open_access": {
    "is_oa": true,
    "oa_status": "bronze",
    "oa_url": "https://www.nature.com/articles/d43747-022-00173-8.pdf",
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2780035454",
      "display_name": "Drug",
      "level": 2,
      "score": 0.6583615
    },
    {
      "id": "C2779679103",
      "display_name": "Degradation (telecommunications)",
      "level": 2,
      "score": 0.5657299
    },
    {
      "id": "C98274493",
      "display_name": "Pharmacology",
      "level": 1,
      "score": 0.3427655
    },
    {
      "id": "C41008148",
      "display_name": "Computer science",
      "level": 0,
      "score": 0.27049828
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.16144413
    },
    {
      "id": "C76155785",
      "display_name": "Telecommunications",
      "level": 1,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T12534",
      "display_name": "Protein Degradation and Inhibitors",
      "score": 0.989
    },
    {
      "id": "T10211",
      "display_name": "Computational Drug Discovery Methods",
      "score": 0.9633
    },
    {
      "id": "T10404",
      "display_name": "Enzyme Catalysis and Immobilization",
      "score": 0.928
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1038/d43747-022-00173-8",
  "pdf_url": "https://www.nature.com/articles/d43747-022-00173-8.pdf",
  "retrieved_date": "2025-07-30T14:14:12.424629",
  "source_database": "OpenAlex"
}